New Delhi, April 2 -- To prevent misuse of weight-loss drugs-given the inflow of low-cost generics after the patent on semaglutide, the key ingredient of Ozempic and Wegovy, expired on March 20-the drugs control department of Delhi has started training chemists to curb their sale without medical prescriptions. The department, in collaboration with the Drugs Controller General of India (DCGI), is also conducting surprise inspections across the city. An official with the state drug control department, who did not wish to be named, said, "Following the advisory issued by the central government over concerns on the anticipated misuse of the generic weight-loss drugs, the department has taken multiple inspections to see if there are malpractices...